The purpose of this study is to calibrate the performance of RBA-2 using people by comparing the results against a standard diagnostics test. The objective of this study is to collect non-invasive in vivo saliva from confirmed cases of both infected and non-infected COVID-19 patients or site staff at the testing site and compare the test results using the RBA-2 against the standard test results used for diagnosis.
The comparison of the results obtained from the current testing methods will be used to calibrate machine learning algorithms of the RBA-2.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Participants can be patients or staff members at the testing site.
Potential participants may be enrolled if:
1. They are identified as requiring a standard diagnostic test for COVID-19 or are being treated after testing positive for COVID-19;
2. They are age ≥ 18 years old;
3. They are willing and able to provide verbal informed consent.
You may not be if
Patients receiving active treatment with antivirals, chloroquine or immune modulators.
Clareo Health | A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device
